AMWL
ARDT

Robert Thomas Webb

Known title: DirectorCIK: 0001951658

Robert Thomas Webb's purchase track record

Robert Thomas Webb has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
11/8/2024ARDT$340K-8.4%-11.3%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

Doximity AI investment news highlights AMWL sector context. Recent coverage focuses on Doximity's ability to shrink its share count through AI investments. This is relevant to AMWL as it highlights broader trends in the healthcare technology sector. While no direct news was reported for American Well, the sector focus provides context for its current trading position.

this person other insiders at AMWL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

ARDT Schedules Q3 2026 Results Call and Webcast. Ardent Health announced the date for its third quarter 2026 earnings conference call and webcast. The call will provide management’s discussion of the latest financial results and operational updates. Investors often use such events to assess performance trends, especially as the stock currently shows strong momentum on the chart.

this person other insiders at ARDT

Transaction History

AMWL▲ Buy$0
ARDT▲ Buy$0
ARDT▲ Buy$0
ARDT▲ Buy$0
ARDT▲ Buy$175K
ARDT▲ Buy$165K
ARDT▲ Buy$0
AMWL▲ Buy$0
AMWL▲ Buy$0
AMWL▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.